Latest news
Q2 2026 CytomX Therapeutics Inc Earnings Call Transcript - GuruFocusGuruFocus · Sun, 09 Aug 2026 18:16:41 GMTCytomX Therapeutics (NASDAQ:CTMX) Announces Earnings Results - MarketBeatMarketBeat · Sat, 08 Aug 2026 04:52:38 GMTCytomX Therapeutics, Inc. Stock 12‑Month Price Target Cut to $12.38, Implies 267% Upside - TradingViewTradingView · Fri, 07 Aug 2026 21:20:13 GMTState Street Corporation (CTMX) reports 5.4% beneficial stake in CytomX Therapeutics - Stock TitanStock Titan · Fri, 07 Aug 2026 13:21:14 GMTCytomX Therapeutics Inc (CTMX) (Q2 2026) Earnings Call Highlight - GuruFocusGuruFocus · Fri, 07 Aug 2026 06:37:27 GMTCytomX Therapeutics secures $37M from Regeneron amid Q2 revenue miss - scanx.tradescanx.trade · Fri, 07 Aug 2026 02:21:26 GMTCytomX Therapeutics Q2 Earnings Call Highlights - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 01:03:00 GMTCTMX Looks 1148.1% Overvalued on GF Value™ - GuruFocusGuruFocus · Fri, 07 Aug 2026 00:48:23 GMT